1. Targeting Pili in Enterococcal Pathogenesis
- Author
-
Barrett R. Harvey, Ali Azhdarinia, Holly Robinson, Peng Gao, Eva M. Sevick-Muraca, Nathaniel Wilganowski, Sukhen C. Ghosh, Kavindra V. Singh, Barbara E. Murray, and Kenneth L. Pinkston
- Subjects
medicine.drug_class ,Immunology ,Monoclonal antibody ,Microbiology ,Pilus ,Enterococcus faecalis ,Fimbriae Proteins ,chemistry.chemical_compound ,medicine ,Animals ,Gram-Positive Bacterial Infections ,biology ,Immunization, Passive ,Biofilm ,Antibodies, Monoclonal ,Endocarditis, Bacterial ,biology.organism_classification ,Virology ,Rats ,Disease Models, Animal ,Infectious Diseases ,chemistry ,Biofilms ,Fimbriae, Bacterial ,Microbial Immunity and Vaccines ,Monoclonal ,biology.protein ,Parasitology ,Peptidoglycan ,Antibody - Abstract
Passive protection, the administration of antibodies to prevent infection, has garnered significant interest in recent years as a potential prophylactic countermeasure to decrease the prevalence of hospital-acquired infections. Pili, polymerized protein structures covalently anchored to the peptidoglycan wall of many Gram-positive pathogens, are ideal targets for antibody intervention, given their importance in establishing infection and their accessibility to antibody interactions. In this work, we demonstrated that a monoclonal antibody to the major component of Enterococcus faecalis pili, EbpC, labels polymerized pilus structures, diminishes biofilm formation, and significantly prevents the establishment of a rat endocarditis infection. The effectiveness of this anti-EbpC monoclonal provides strong evidence in support of its potential as a preventative. In addition, after radiolabeling, this monoclonal identified the site of enterococcal infection, providing a rare example of molecularly specific imaging of an established bacterial infection and demonstrating the versatility of this agent for use in future diagnostic and therapeutic applications.
- Published
- 2014
- Full Text
- View/download PDF